Analysts Viewpoint LTRN short interest jump by 49.7%, reflecting negative sentiment Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Lantern Pharma
Insiders Updates Days-to-cover ratio for LTRN declines to 5.2 due to decline in short interest Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Lantern Pharma
Stock Earnings H.C. Wainwright’s latest rating for LTRN stock Lantern Pharma Inc’s filing revealed that its 10% Owner Fletcher Aaron G.L. unloaded Company’s shares for reported $0.12 million on
Stock Earnings Understanding the Risks of Investing in Lantern Pharma Inc (LTRN) Lantern Pharma Inc’s filing revealed that its 10% Owner Fletcher Aaron G.L. unloaded Company’s shares for reported $0.12 million on